Follow
Christopher M Knapp
Christopher M Knapp
Principal Engineer, Moderna Inc
Verified email at modernatx.com
Title
Cited by
Cited by
Year
Branched‐Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pH
KA Hajj, RL Ball, SB Deluty, SR Singh, D Strelkova, CM Knapp, ...
Small 15 (6), 1805097, 2019
1832019
Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model
RL Ball, CM Knapp, KA Whitehead
PloS one 10 (7), e0133154, 2015
442015
In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphoma
CM Knapp, KA Whitehead
Expert opinion on drug delivery 11 (12), 1923-1937, 2014
352014
Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma
CM Knapp, J He, J Lister, KA Whitehead
Experimental Biology and Medicine 241 (9), 1007-1013, 2016
292016
Lipidoid tail structure strongly influences siRNA delivery activity
CM Knapp, P Guo, KA Whitehead
Cellular and Molecular Bioengineering 9 (3), 305-314, 2016
192016
Lipid nanoparticle siRNA cocktails for the treatment of mantle cell lymphoma
CM Knapp, J He, J Lister, KA Whitehead
Bioengineering & translational medicine 3 (2), 138-147, 2018
152018
Development of a clinically relevant chemoresistant mantle cell lymphoma cell culture model
J He, KA Hajj, CM Knapp, KA Whitehead
Experimental Biology and Medicine 244 (11), 865-872, 2019
22019
The system can't perform the operation now. Try again later.
Articles 1–7